Charles River Laboratories International Inc (CRL)

Industry Diagnostics & Research

This stock can be held in an Investment Account

Sell

$165.00

Buy

$200.00

arrow-down$-1.40 (-0.72%)

Prices updated at 13 Dec 2025, 00:16 EST

Prices minimum 15 mins delay

Prices in USD

Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. James C. Foster

CEO

Mr. James C. Foster

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

20,100

Head office

251 Ballardvale Street

Wilmington

United States

01887

+1 781 222-6000

askcharlesriver@crl.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Michael Gunnar Knell Interim Chief Financial Officer, Corporate Senior Vice President and Chief Accounting Officer	-
Mr. Paul W. Graves Director	-
Mr. Mark Joseph Enyedy Director	-
Mr. Steven K. Barg Director	-
Mr. Abe Ceesay Director	-
Mr. James C. Foster Chairman of the Board, President and Chief Executive Officer	1.51m
Dr. Martin W. Mackay, PhD Independent Director	0.09m
Dr. Craig B. Thompson,M.D. Independent Director	0.07m
Ms. Virginia M. Wilson Independent Director	0.09m
Ms. Victoria L. Creamer Corporate Executive Vice President	0.54m
Dr. Nancy C. Andrews, M.D.,PhD Independent Director	0.09m
Ms. Birgit Girshick Chief Operating Officer	0.74m
Mr. Joseph W. LaPlume Corporate Executive Vice President, Corporate Development and Strategy	0.56m
Mr. George Llado, Sr Independent Director	0.07m
Ms. Shannon M. Parisotto Corporate Executive Vice President	-
Ms. Reshema Kemps-Polanco Independent Director	0.08m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	5,811,754
BlackRock Inc	3,856,066
Wellington Management Group, LLP	3,740,768
Wellington Management Company LLP	3,190,467
Allspring Global Investments Holdings, LLC	2,177,941

Director dealings

Date chevron-l-regular chevron-r-regular	Action
08 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
06 Nov 2024	-
12 Aug 2024	-
08 Aug 2024	-
01 Aug 2024	-
03 Jun 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.